DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 78 filers reported holding DICE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $485,275 | -22.3% | 10,445 | -52.1% | 0.01% | -23.5% |
| Q1 2023 | $624,828 | +102.7% | 21,809 | +120.8% | 0.02% | +88.9% |
| Q4 2022 | $308,194 | -13.7% | 9,878 | -43.9% | 0.01% | -30.8% |
| Q3 2022 | $357,000 | +2.3% | 17,605 | -21.7% | 0.01% | -18.8% |
| Q2 2022 | $349,000 | +13.3% | 22,497 | +39.9% | 0.02% | +14.3% |
| Q1 2022 | $308,000 | – | 16,084 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 3,292,871 | $62,993,000 | 33.95% |
| Sands Capital Ventures, LLC | 3,148,970 | $60,240,000 | 12.58% |
| OUP Management Co., LLC | 536,693 | $10,267,000 | 7.82% |
| New Leaf Venture Partners, L.L.C. | 556,693 | $10,650,000 | 5.25% |
| Logos Global Management LP | 1,385,251 | $26,500,000 | 3.44% |
| Soleus Capital Management, L.P. | 983,994 | $18,824,000 | 2.43% |
| RA Capital Management | 5,208,911 | $99,646,000 | 2.17% |
| Deep Track Capital, LP | 1,250,000 | $23,913,000 | 1.53% |
| Samsara BioCapital, LLC | 228,466 | $4,371,000 | 1.10% |
| HighVista Strategies LLC | 48,960 | $937,000 | 0.60% |